Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Marker, Biological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02541916
What this trial is testing

Liver Immune Tolerance Marker Utilization Study

Who this might be right for
ImmunosuppressionImmune Tolerance
University of Toronto 69
Not applicableEnded earlyNCT02579993
What this trial is testing

ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation

Who this might be right for
Limbal Stem Cell Deficiency
Instituto de Oftalmología Fundación Conde de Valenciana 10
Not applicableStudy completedNCT03080168
What this trial is testing

The "AIM Study": Investigating Whether Actigraphy and Ideation Measures Can Promote Patient Safety

Who this might be right for
Suicidal IdeationSuicidal BehaviorMental Health Symptoms+1 more
VA Office of Research and Development 220
Early research (Phase 1)Study completedNCT01062347
What this trial is testing

A Novel Bio-marker of Zinc Status

Who this might be right for
Zinc Deficiency
International Centre for Diarrhoeal Disease Research, Bangladesh
Not applicableWithdrawnNCT03027076
What this trial is testing

Microbiome of Urologic Chronic Pelvic Pain Syndrome

Who this might be right for
ProstatitisChronic ProstatitisInterstitial Cystitis+2 more
Johns Hopkins University
Not applicableStudy completedNCT03988140
What this trial is testing

Apico-coronal Position of the Implant in Edentulous Diabetics With Implant-retained Overdentures

Who this might be right for
Diabetes MellitusDental Implants
Paulista University 22
Not applicableUnknownNCT03606850
What this trial is testing

Transcranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY Study

Who this might be right for
Major Depressive Disorder
Centre Hospitalier du Rouvray 22
Not applicableStudy completedNCT03270358
What this trial is testing

OStéopontin as a Marker Of StenoSIS - OSMOSIS

Who this might be right for
Stenosis
Centre Hospitalier Universitaire de Nice 76
Not applicableStudy completedNCT03334968
What this trial is testing

Prolidase Enzyme Activity in Stroke Patients

Who this might be right for
Stroke, IschemicProlidase Deficiency
Bezmialem Vakif University 74
Early research (Phase 1)Ended earlyNCT00124917
What this trial is testing

Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 6
Not applicableUnknownNCT00155740
What this trial is testing

Mesothelin as a New Tumor Marker for Ovarian Cancer

Who this might be right for
Ovarian Cancer
National Taiwan University Hospital 250
Post-approval studies (Phase 4)UnknownNCT01835613
What this trial is testing

Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.

Who this might be right for
Rheumatoid Arthritis (RA)
Osservatorio Epidemiologico GISEA 150
Not applicableLooking for participantsNCT07518862
What this trial is testing

Heart Rate VAriability as a MaRker for tItrATing hIgh flOw Nasal Cannula Therapy

Who this might be right for
Respiratory FailureHeart Rate Variability (HRV)High Flow Nasal Cannula
University Health Network, Toronto 20
Not applicableNot Yet RecruitingNCT07535125
What this trial is testing

IPEX Study: Pancreatic Exocrine Insufficiency as a Functional Marker of Disease Progression in Patients With IPMN

Who this might be right for
Intraductal Papillary Mucinous NeoplasmsPancreatic Exocrine Insufficiency
A.O.U. Città della Salute e della Scienza 600
Not applicableStudy completedNCT02911246
What this trial is testing

Evaluation Report of the Urea / Urine Creatinine as a Marker of Nutritional Status Predictive of ICU Care Associated Infections

Who this might be right for
Brain InjuryMalnutrition
Nantes University Hospital 309
Early research (Phase 1)Study completedNCT00556660
What this trial is testing

Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 20
Not applicableStudy completedNCT05049408
What this trial is testing

Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer

Who this might be right for
Oral Squamous Cell Carcinoma
S&T Biomed Co., Ltd. 1,160
Not applicableUnknownNCT00740740
What this trial is testing

Biomarkers of Aneurysm Wall Strength

Who this might be right for
Abdominal Aortic Aneurysm
Radboud University Medical Center 50
Not applicableStudy completedNCT02941874
What this trial is testing

Determining of Normal Values and Conformity Assessment of the Dosage of a Plasmatic Marker of the Cellular Captation of Glucose: the IRAP Protein

Who this might be right for
Insulin Resistance
University Hospital, Grenoble 96
Early research (Phase 1)Study completedNCT01621490
What this trial is testing

PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma

Who this might be right for
Advanced MelanomaMetastatic Melanoma
Bristol-Myers Squibb 170
Next Page